SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

SI-BONE, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$19.66−0.02 (-0.10%)

Close on Oct 19, 2026

Market cap: $874.42M
P/E (TTM): –
Dividend yield: 0.00%

Dividends

Si-Bone has not reported a dividend

No dividend per share appears in Si-Bone's annual filings since fiscal 2016.

Where these numbers come from

Parsed from the XBRL in Si-Bone's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SIBN.

Revenue growth15.3% · median 3.1%

Gross margin79.5% · median 73.7%

Operating margin-8.3% · median -11.9%

Net margin-6.9% · median -15.7%

Company	Revenue	Growth
BVS	$581.85M	+3.1%
KIDS	$252.73M	+14.5%
SIBN	$213.60M	+15.3%
TMCI	$205.31M	-4.0%
XTNT	$109.53M	-14.3%
SI	$60.06M	+60.9%

Company

Next earnings (est.): Nov 9, 2026, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 376
Held by institutions: 100.0%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1459839

Advertisement
300 × 250